Day: May 8, 2020

MONTRÉAL, 08 mai 2020 (GLOBE NEWSWIRE) — Groupe WSP Global Inc. (TSX : WSP) (« WSP » ou la « Société ») a tenu le 7 mai 2020 son assemblée annuelle des actionnaires (l’« assemblée ») de façon virtuelle. Un total de 85 731 872 actions ordinaires (représentant approximativement 81 % de toutes les actions ordinaires émises et en circulation de la Société) étaient représentées à l’assemblée. WSP annonce que les actionnaires de la Société (les « actionnaires ») ont adopté tous les points inscrits à l’ordre du jour de l’assemblée par la Société. Les résultats du vote sur chaque point à l’ordre du jour de l’assemblée sont les suivants.ÉLECTION DES ADMINISTRATEURSLe conseil d’administration de la Société avait fixé à huit le nombre d’administrateurs (les « administrateurs ») qui devaient être élus à l’assemblée....

MAYFIELD VILLAGE, OHIO, May 08, 2020 (GLOBE NEWSWIRE) — The Board of Directors of The Progressive Corporation (NYSE:PGR) today declared a $0.10 per common share dividend, payable July 15, 2020, to shareholders of record at the close of business on July 7, 2020 (ex-dividend date of July 6, 2020). About Progressive The Progressive Group of Insurance Companies makes it easy to understand, buy and use auto insurance. Progressive offers choices so consumers can reach us whenever, wherever and however it’s most convenient – online at progressive.com, by phone at 1-800-PROGRESSIVE, on a mobile device or in-person with a local agent.Progressive provides insurance for personal and commercial autos and trucks, motorcycles, boats, recreational vehicles, and homes; it is the third largest auto insurer in the country, a leading seller...

BEIJING, CHINA, May 08, 2020 (GLOBE NEWSWIRE) — China Liberal Education Holdings Limited (Nasdaq: CLEU) (“China Liberal”), an educational services provider in China, today announced that its ordinary shares have commenced trading on The Nasdaq Capital Market under the ticker symbol “CLEU”.China Liberal priced its initial public offering (“IPO”) of 1,333,333 ordinary shares at $6.00 per ordinary share, before underwriting discounts and offering expenses, resulting in gross proceeds of $8,000,000. The offering was conducted on a firm commitment basis and is expected to close on May 12, 2020, subject to customary closing conditions.Boustead Securities, LLC (“Boustead”), acted as the sole underwriter for the offering, with Zinvest Global Limited in Hong Kong serving as Asian book runner. Hunter Taubman Fischer & Li LLC acted as counsel...

BRIDGEWATER, N.J., May 08, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 first quarter financial results on Tuesday, May 12, 2020, after the close of the U.S. financial markets.Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows:About Osmotica Pharmaceuticals plcOsmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories,...

Sudbury, Ontario, May 08, 2020 (GLOBE NEWSWIRE) — On April 3, the Vale COVID-19 challenge was launched in Canada to help propel innovative COVID-19 solutions developed by companies, startups, institutions, universities or professionals into the marketplace by offering financial support of up to USD $1M.A total of nearly 1,800 solutions were submitted globally, of which over 300 came from within Canada. All solutions were carefully reviewed by a select group of employees as well as external partners and supporters, which, in Canada, included:Mater Dei Hospital in Brazil,Dr. Ken Jenkins (Horizon supported by TELUS Health),Dr. Farrell Cahill (Medisys supported by TELUS Health),Dr. Greg Ross (Health Sciences North Sudbury),Don Duval (NORCAT),Dr. Shahid Husain (University Health Network)Sheryl Thingvold (MaRS Discovery District).“The participation...

Hoivatilat PlcStock exchange release8 May 2020 at 7.50 pm EESTArbitral tribunal has confirmed Aureit Holding Oy’s redemption right regarding Hoivatilat’s minority shares and trading in Hoivatilat’s shares will be suspendedThe arbitral tribunal appointed by the Redemption Board of the Finland Chamber of Commerce has today confirmed that Aureit Holding Oy (“Aureit Holding”) has the right to redeem the minority shares in Hoivatilat Plc (“Hoivatilat”) and that Aureit Holding has the right to obtain title to the minority shares by posting a security approved by the arbitral tribunal for the payment of the redemption price and the interest accruing thereon.Following Hoivatilat’s application, Nasdaq Helsinki Ltd (“Nasdaq Helsinki”) has on 23 April 2020 confirmed that that the quotation...

Hoivatilat OyjPörssitiedote8.5.2020 klo 19:50 EESTVälimiesoikeus on vahvistanut Aureit Holding Oy:n lunastusoikeuden Hoivatilojen vähemmistöosakkeisiin ja kaupankäynti Hoivatilojen osakkeilla keskeytetäänKeskuskauppakamarin lunastuslautakunnan nimittämä välimiesoikeus on tänään vahvistanut, että Aureit Holding Oy:llä (“Aureit Holding”) on oikeus lunastaa Hoivatilat Oyj:n (“Hoivatilat”) vähemmistöosakkeet ja että Aureit Holdingilla on oikeus saada vähemmistöosakkeet omistukseensa asettamalla lunastushinnan ja sille kertyvän koron maksamisesta välimiesoikeuden hyväksymä vakuus.Nasdaq Helsinki Oy (“Nasdaq Helsinki”) on 23.4.2020 Hoivatilojen hakemuksen johdosta vahvistanut, että Hoivatilojen osakkeiden noteeraus Nasdaq Helsingin pörssilistalla päättyy mahdollisimman pian sen jälkeen, kun Aureit Holding...

TRYbeCA-1 Phase-III-Studie:Mehr als 75 % der ca. 500 geplanten Patienten wurden bereits aufgenommenFast-Track-Status von US-amerikanischer FDA zuerkanntStudie soll wie geplant nach dritter unabhängiger Sicherheitsüberprüfung fortgesetzt werdenDie Interims-Überlegenheitsanalyse wird zum Jahresende erwartet und die abschließende Analyse in der zweiten Jahreshälfte 2021Barposition in Höhe von 58,6 Millionen Euro (64,6 Millionen US-Dollar) am Ende des ersten Quartals 2020LYON, Frankreich und CAMBRIDGE, Mass., May 08, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq und Euronext: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, gab heute ein Update zum Unternehmen und der Finanzlage.„In den vergangenen...

Studio di fase 3 TRYbeCA-1:Più del 75% dei circa 500 pazienti previsti è stato arruolatoDesignazione Fast-Track concessa dalla FDA statunitenseLo studio continuerà come previsto dopo la terza valutazione indipendente sulla sicurezzaAnalisi di superiorità ad interim prevista intorno alla fine dell’anno e analisi finale nel secondo semestre del 2021Posizione finanziaria di €58,6 milioni ($64,6 milioni) alla fine del primo trimestre 2020LIONE, Francia, e CAMBRIDGE, Mass., May 08, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), un’azienda biofarmaceutica in fase clinica che sviluppa terapie innovative incapsulando sostanze farmacologiche all’interno dei globuli rossi, ha presentato oggi un aggiornamento sulle attività della società e sui suoi dati finanziari.“In queste ultime settimane della pandemia di COVID-19,...